EMA Sees Decision on CureVac Covid Shot Unlikely Before Year-End

The European Medicines Agency will be in a better position by the end of the year to understand the next steps for CureVac’s first-generation Covid-19 shot, agency officials said on Thursday.

• CureVac has filed data “that are quite important for us as a starting point to see where we are with this application,” Marco Cavaleri, head of biological health threats and vaccines strategy, says in press briefing. “We expect that by the end of the year we will be in a better position to really understand what could be the next step for this vaccine”
• Separately, agency will ...